Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat
Authors:
- 1 May 2016
- journal article
- Published by Elsevier in Life Sciences
- Vol. 152, 199-209
Abstract
No abstract availableKeywords
Funding Information
- Earmarked Fund for Modern Agro-industry Technology Research System (CARS-36)
- National Natural Science Foundation of China (31201809)
This publication has 52 references indexed in Scilit:
- Cellular and Molecular Basis of Intestinal Barrier Dysfunction in the Irritable Bowel SyndromeGut and Liver, 2012
- The antimicrobial peptide cathelicidin modulates Clostridium difficile -associated colitis and toxin A-mediated enteritis in miceGut, 2012
- Cathelicidin Signaling via the Toll-like Receptor Protects Against Colitis in MiceGastroenterology, 2011
- Optimizing culture conditions of a porcine epithelial cell line IPEC-J2 through a histological and physiological characterizationCytotechnology, 2011
- Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein KinasesMicrobiology and Molecular Biology Reviews, 2011
- The roles of tumor necrosis factor-alpha in colon tight junction protein expression and intestinal mucosa structure in a mouse model of acute liver failureBMC Gastroenterology, 2009
- Snake Cathelicidin from Bungarus fasciatus Is a Potent Peptide AntibioticsPLOS ONE, 2008
- Changes in small intestinal nutrient transport and barrier function after lipopolysaccharide exposure in two pig breeds1Journal of Animal Science, 2007
- The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctionsCanadian Journal of Physiology and Pharmacology, 2006
- Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC-6 rat intestinal crypt cellsJournal of Cellular Physiology, 1997